Screener
Phathom Pharmaceuticals, Inc. PHAT Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324867
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Stockholders’ deficit: | ||
| Preferred stock, $0.0001 par value; authorized shares — 40,000,000 at June 30, 2026 and December 31, 2025; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; authorized shares — 400,000,000 at June 30, 2026 and December 31, 2025; issued and outstanding shares — 80,070,048 and 71,419,025 at June 30, 2026 and December 31, 2025, respectively | 8 | 6 |
| Treasury stock — 19 shares at June 30, 2026 and December 31, 2025 | — | — |
| Additional paid-in capital | 1,187,928 | 1,046,083 |
| Accumulated deficit | (1,532,209) | (1,484,258) |
| Total stockholders’ deficit | (344,273) | (438,169) |
| Total liabilities and stockholders’ deficit | $327,075 | $259,149 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Phathom Pharmaceuticals, Inc.'s total equity?
- Phathom Pharmaceuticals, Inc. (PHAT) reported total equity of -$344.27M in Q2 2026.
- How has Phathom Pharmaceuticals, Inc.'s total equity changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s total equity increased by 15.2% year-over-year, from -$405.83M to -$344.27M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s total equity?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s total equity has grown at a 17.7% compound annual growth rate (CAGR), from $194.27M to -$438.17M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Phathom Pharmaceuticals, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude